Bulk profiling of tumour specimens suggests that only PDGFRA is common to 4q12 amplified cases, with 39% of these harbouring PDGFRA amplification alone, 23% including PDGFRA and KIT, and 38% encompassing all three RTKs [5]. The gene discussed is KIT; the disease is neoplasm.